Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-30

Clinical Trial Update: Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral digoxin in people with amyotrophic lateral sclerosis is currently active but not recruiting. The study is sponsored by Massachus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Status: ACTIVE_NOT_RECRUITING